NewslettersMammary Cell NewsChemotherapy Induces ACE2 Expression in Breast Cancer via the ROS-AKT-HIF-1α Signaling Pathway: A Potential Prognostic Marker for Breast Cancer Patients Receiving ChemotherapyBy Laurisa Dohm - November 10, 2022079Small interfering RNAs or lentivirus-mediated shRNA was used to silence ACE2 and HIF-1α expression in cellular models.[Journal of Translational Medicine]Full Article